Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations

NEWS
Defence
By Sara Lavallin•12 February 2026
Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations

Morphose Capital Partners, London-based specialists in Mergers and Acquisitions, corporate restructuring and finance, today announces the launch of its Defence and Resilience division (MD&R). The division has been created to align dual-use innovation, industrial capability, defence priorities and strategic capital at the speed demanded by modern defence, ensuring that capital, technology and operational requirements converge fast enough to meet the realities of contemporary threats and conflict.

As peace-time dividends erode, long-held alliances rupture and the UK Ministry of Defence strives to modernise, rearm and innovate at wartime pace, the gap between critical innovations and the finance needed to productise and deploy them has become a strategic vulnerability. However, capital alone will not deliver security. Capital must be intelligently curated, directed into the industries, technologies and procurement pathways that transform innovation into operational advantage and sovereign capability.
Morphose Defence and Resilience brings together a highly accomplished team, from across defence, capital markets and fundraising, with a rare combination of first-hand battlefield and defence procurement experience and a proven pedigree in scaling and financing transformative technologies. The team is united and driven by a real sense of mission to defend sovereignty, protect critical national infrastructure and strengthen economic resilience.

With tangible spheres of knowledge and influence across defence strategy and procurement, combined with a deep finance backbone and networks spanning venture capital, private equity, defence primes and the wider investment community, MD&R brings unparalleled connectivity between capital and defence priorities. It equips strategic capital with the knowledge and confidence to invest in defence, and enables innovators and industry to access the capital required to develop and deliver next generation dual-use applications and armaments.

Leadership and Team

MD&R is led by Morphose’s CEO Andre Turville, who also serves as Mentor-in-Residence with Janus Allies (UK Defence Innovation (UKDI), NATO DIANA), guiding dual-use and defence-grade technology companies. Andre has unique insight into the requirements, strategic priorities and pathways through which innovation is embedded into defence. Previously, Andre founded ARX Alliance, built a CNI cyber resilience platform, and led direct investment in climate tech, bio-tech, and sustainable infrastructure across Europe and ASEAN. His achievements reflect consistent success in bringing strategic capital and critical technologies together to build resilient, innovative capabilities.
Morphose has strengthened MD&R with two new, highly distinguished appointments, and is pleased to welcome:

Robin Anderton-Brown

Former Director of Capability at UK Strategic Command, with a distinguished 30-year military career and responsibility for Defence’s most diverse capability portfolio spanning digital, intelligence along with the specialist and strategic enabling systems to ensure multi-domain integration. His expertise in defence strategic needs and acquisition processes, from S&T programmes, innovation initiatives through to major procurement programmes, adds real value for clients seeking access to the defence ecosystem.

Picture 1

James Roddis DSO MBE

Former Director of Strategy at UK Strategic Command (now Cyber and Specialist Operations Command). He has extensive conventional and specialist operational leadership across Afghanistan, the Middle East and Ukraine, and strategic experience from the highest echelons of the UK Ministry of Defence including input into Defence Reviews, Military Strategic planning and transformational change programmes. His experience links the frontline reality to capability and policy intent.

Andre Turville, Morphose CEO, comments “We’re incredibly proud to welcome Robin and James into the MD&R team. Their distinguished military careers, operational and strategic knowledge will be immeasurably valuable to MD&R. We passionately believe that our combined skillsets and spheres of knowledge and influence will help connect capital with critical innovations and industry, accelerating deployment at scale to deliver sovereign advantage.”

1727354667315

MD&R supports:-

• Scale-ups and innovators navigate the complexities of defence procurement and compliance, and provide access to funding to accelerate contract mobilisation and production scale-up

• Investors and capital providers build responsible, high yielding defence portfolios by providing accurate insights into defence priorities and support with due diligence in classified environments.

• Defence primes identify and integrate innovations through M&A, and strengthen supply chains.

Morphose Capital Partners Team

About Morphose Capital Partners

Morphose Capital Partners is a leading advisory firm specializing in mergers & acquisitions, corporate finance, and strategic transactions for owner-managed businesses across the UK.

With decades of combined experience, our team provides expert guidance through every stage of your business journey – from early-stage funding and growth capital to strategic exits and business sales.

We pride ourselves on building long-term relationships with our clients, offering personalized service and deep sector expertise to help you achieve your business objectives while maximizing value at every opportunity.

Related Articles

Can The Ghost of CGT Past Forecast What's to Come?
NEWS
3 November 2025By Elena Balsera

Can The Ghost of CGT Past Forecast What's to Come?

Can the Ghost of CGT Past Forecast What's to Come? In our capacity as M&A advisors, we’re often asked what we think will happen to Capital Gains Tax next month (unfortunately, despite all our combined expertise we can’t fully demystify this one). However, a plotted history of CGT since its inception in 1965, not only reveals how different governments have viewed capital wealth generation, it also signals what might just come next......

Read More
Introducing Dr Tom McColm
NEWS
3 November 2025By Elena Balsera

Introducing Dr Tom McColm

Morphose is delighted to welcome Dr. Tom McColm as an advisor, bringing a powerful mix of academic excellence and commercial expertise in cleantech and deep-tech ventures. His proven track record in developing and scaling innovative technologies will strengthen Morphose’s advisory capabilities in critical infrastructure and defence.

Read More
Welcoming Elena Balsera to the Morphose Team
NEWS
14 October 2025By Elena Balsera

Welcoming Elena Balsera to the Morphose Team

We’re excited to welcome Elena Balsera to Morphose! After a successful summer internship, Elena joins full-time, bringing her multilingual skills, international relations and business expertise, and strong digital and design talents to our team.

Read More